中文产业新闻评分62Chinese source
武田 Rusfertide 获 FDA 批准上市，用于治疗真性红细胞增多症
武田 first-in-class 疗法获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
武田 first-in-class 疗法获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.